Diabetes Care 26:2426-2432, 2003
© 2003 by the American Diabetes Association, Inc.
Pathophysiology/Complications Original Article |
Quantitative Insulin Sensitivity Check Index and the Reciprocal Index of Homeostasis Model Assessment in Normal Range Weight and Moderately Obese Type 2 Diabetic Patients
Hisayo Yokoyama, MD1,
Masanori Emoto, MD, PHD1,
Shigehiko Fujiwara, MD1,
Koka Motoyama, MD1,
Tomoaki Morioka, MD1,
Miyoko Komatsu, MD, PHD1,
Hideki Tahara, MD, PHD1,
Tetsuo Shoji, MD, PHD1,
Yasuhisa Okuno, MD, PHD2 and
Yoshiki Nishizawa, MD, PHD1
1 Osaka City University Graduate School of Medicine, Metabolism, Endocrinology and Molecular Medicine, Osaka, Japan
2 Osaka City University Graduate School of Medicine, Cardiovascular Medicine, Institute of Geriatrics and Medical Science, Osaka, Japan
Address correspondence and reprint requests to Masanori Emoto, Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, Japan, 545-8585. E-mail: memoto{at}med.osaka-cu.ac.jp
OBJECTIVETo investigate whether the quantitative insulin sensitivity check index (QUICKI) and the reciprocal index of homeostasis model assessment (1/HOMA-IR) derived from fasting plasma glucose and insulin level are excellent surrogate indices of insulin resistance in both normal range-weight and moderately obese type 2 diabetic and healthy subjects.
RESEARCH DESIGN AND METHODSThe association between QUICKI or 1/HOMA-IR and insulin resistance index assessed by euglycemic-hyperinsulinemic clamp (clamp-IR) was investigated in 121 type 2 diabetic and 29 healthy subjects recruited from among 120 (age 55 ± 11, 48 ± 15, and 52 ± 15 years [means ± SD], respectively). Type 2 diabetic subjects were divided into groups of 76 normal range-weight and 45 moderately obese subjects (BMI 21.4 ± 2.3 vs. 27.2 ± 2.2 kg/m2, P < 0.0001).
RESULTSQUICKI and 1/HOMA-IR were significantly lower in the moderately obese group than in the normal range-weight type 2 diabetic and healthy groups (n = 120) (QUICKI, 0.338 ± 0.030, 0.371 ± 0.037, and 0.389 ± 0.041, respectively, P < 0.0001; 1/HOMA-IR, 0.50 ± 0.33, 0.92 ± 0.55, and 1.24 ± 0.82, P < 0.0001). QUICKI was strongly correlated with clamp-IR in normal range-weight, moderately obese type 2 diabetic, and healthy subjects (r = 0.641, 0.570, and 0.502, respectively; all subjects, r = 0.608, P < 0.01) and 1/HOMA-IR exhibited correlations comparable to those of QUICKI with clamp-IR (r = 0.637, 0.530, and 0.461, respectively; all subjects, r = 0.589, P < 0.001). In multiple regression models including QUICKI or 1/HOMA-IR as an independent variable, the estimation formula accounted for 55% of the variability of clamp-IR for the group of all type 2 diabetic subjects (R2 = 0.547 and 0.551, respectively, P 0.0001).
CONCLUSIONSQUICKI and 1/HOMA-IR were highly correlated with clamp-IR, with comparable coefficients in both normal range-weight and moderately obese type 2 diabetic patients and nondiabetic subjects. The latter can probably be applied clinically in view of its convenience.
Abbreviations: FIRI, fasting immunoreactive insulin FPG, fasting plasma glucose HOMA, homeostasis model assessment HOMA-IR, HOMA of insulin resistance 1/HOMA-IR, reciprocal of HOMA-IR OHA, oral hypoglycemic agent QUICKI, quantitative insulin sensitivity check index SSPI, steady-state plasma insulin

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Musso, R. Gambino, S. Bo, B. Uberti, G. Biroli, G. Pagano, and M. Cassader
Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome?: A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects
Diabetes Care,
March 1, 2008;
31(3):
562 - 568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lee, R. Muniyappa, X. Yan, H. Chen, L. Q. Yue, E.-G. Hong, J. K. Kim, and M. J. Quon
Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice
Am J Physiol Endocrinol Metab,
February 1, 2008;
294(2):
E261 - E270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Velasquez-Mieyer, C. P. Neira, R. Nieto, and P. A. Cowan
Review: Obesity and cardiometabolic syndrome in children
Therapeutic Advances in Cardiovascular Disease,
October 1, 2007;
1(1):
61 - 81.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Boyko and C. C. Jensen
Do We Know What Homeostasis Model Assessment Measures?: If not, does it matter?
Diabetes Care,
October 1, 2007;
30(10):
2725 - 2728.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Musso, R. Gambino, F. De Michieli, G. Biroli, A. Premoli, G. Pagano, S. Bo, M. Durazzo, and M. Cassader
Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake
Am. J. Clinical Nutrition,
September 1, 2007;
86(3):
661 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L A Gondoni, A Liuzzi, A M Titon, O Taronna, F Nibbio, P Ferrari, and G Leonetti
A simple tool to predict exercise capacity of obese patients with ischaemic heart disease
Heart,
July 1, 2006;
92(7):
899 - 904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yokoyama, M. Emoto, K. Mori, T. Araki, M. Teramura, H. Koyama, T. Shoji, M. Inaba, and Y. Nishizawa
Plasma Adiponectin Level Is Associated with Insulin-Stimulated Nonoxidative Glucose Disposal
J. Clin. Endocrinol. Metab.,
January 1, 2006;
91(1):
290 - 294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Karne, H. Chen, G. Sullivan, and M. J. Quon
Letter re: Limited Accuracy of Surrogates of Insulin Resistance during Puberty in Obese and Lean Children at Risk for Altered Glucoregulation
J. Clin. Endocrinol. Metab.,
July 1, 2005;
90(7):
4418 - 4419.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Chen, G. Sullivan, and M. J. Quon
Assessing the Predictive Accuracy of QUICKI as a Surrogate Index for Insulin Sensitivity Using a Calibration Model
Diabetes,
July 1, 2005;
54(7):
1914 - 1925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Hermans, T. M. Pepersack, L. H. Godeaux, I. Beyer, and A. P. Turc
Prevalence and Determinants of Impaired Glucose Metabolism in Frail Elderly Patients: The Belgian Elderly Diabetes Survey (BEDS)
J. Gerontol. A Biol. Sci. Med. Sci.,
February 1, 2005;
60(2):
241 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Brehm, G. Pfeiler, G. Pacini, H. Vierhapper, and M. Roden
Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity
Clin. Chem.,
December 1, 2004;
50(12):
2316 - 2322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Conus, D. B. Allison, R. Rabasa-Lhoret, M. St-Onge, D. H. St-Pierre, A. Tremblay-Lebeau, and E. T. Poehlman
Metabolic and Behavioral Characteristics of Metabolically Obese but Normal-Weight Women
J. Clin. Endocrinol. Metab.,
October 1, 2004;
89(10):
5013 - 5020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yokoyama, M. Emoto, T. Araki, S. Fujiwara, K. Motoyama, T. Morioka, H. Koyama, T. Shoji, Y. Okuno, and Y. Nishizawa
Effect of Aerobic Exercise on Plasma Adiponectin Levels and Insulin Resistance in Type 2 Diabetes
Diabetes Care,
July 1, 2004;
27(7):
1756 - 1758.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Karne, H. Chen, and M. J. Quon
Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects With Normal Glucose Metabolism: Response to Ascaso et al.
Diabetes Care,
May 1, 2004;
27(5):
1247 - 1248.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yokoyama, M. Emoto, S. Fujiwara, K. Motoyama, T. Morioka, M. Komatsu, H. Tahara, H. Koyama, T. Shoji, M. Inaba, et al.
Quantitative Insulin Sensitivity Check Index and the Reciprocal Index of Homeostasis Model Assessment Are Useful Indexes of Insulin Resistance in Type 2 Diabetic Patients with Wide Range of Fasting Plasma Glucose
J. Clin. Endocrinol. Metab.,
March 1, 2004;
89(3):
1481 - 1484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Sheehan
Polycystic Ovarian Syndrome: Diagnosis and Management
Clin. Med. Res.,
February 1, 2004;
2(1):
13 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|